Title : A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer.

Pub. Date : 2011 Mar

PMID : 20732932






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: AP-D and AC-D are well tolerated and active as NST in EBC. NSC638702 ACD shelterin complex subunit and telomerase recruitment factor Homo sapiens